Helomics Corp-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Helomics Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014395
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Helomics Corp(Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor response to various chemotherapeutic and biologic agents. Helomics’ biospecifx is a biomarker that is used to test drug response and patient prognosis. The company also offers contract research, genefx colon, which is a microarray-based gene signature that identifies patients at risk of recurrence. It serves clinical testing, precision medicine and cancer research needs of physicians. The company has operations in US and Canada. Precision is headquartered in Pittsburgh, Pennsylvania, the US.

Helomics Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Helomics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Helomics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Helomics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Helomics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Helomics Corp, Medical Devices Deals, 2011 to YTD 2017 9
Helomics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Helomics Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Precision Therapeutics Raises US$14 Million In Venture Financing 11
Private Equity 12
Healthcare Royalty Invests USD60 Million in Precision Therapeutics 12
Partnerships 13
Helomics and Pittsburgh Life Sciences Greenhouse Form Joint Venture 13
Helomics Corp – Key Competitors 14
Helomics Corp – Key Employees 15
Helomics Corp – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Strategy And Business Planning 17
Apr 19, 2016: Helomics Announces Second Phase of Realignment Towards a Research and Clinical Products Company in Personalized Healthcare 17
Other Significant Developments 18
Dec 21, 2016: Helomics Announces the Completion of the Third and Final Phase of its Corporate Restructuring Towards Becoming a Fully-Integrated Clinical Contract Research Organization 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Helomics Corp, Pharmaceuticals & Healthcare, Key Facts 2
Helomics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Helomics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Helomics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Helomics Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Helomics Corp, Medical Devices Deals, 2011 to YTD 2017 9
Helomics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Precision Therapeutics Raises US$14 Million In Venture Financing 11
Healthcare Royalty Invests USD60 Million in Precision Therapeutics 12
Helomics and Pittsburgh Life Sciences Greenhouse Form Joint Venture 13
Helomics Corp, Key Competitors 14
Helomics Corp, Key Employees 15

★海外企業調査レポート[Helomics Corp-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IMPAC Mortgage Holdings Inc (IMH):企業の財務・戦略的SWOT分析
    IMPAC Mortgage Holdings Inc (IMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • KPJ Healthcare Berhad (KPJ):企業の財務・戦略的SWOT分析
    Summary KPJ Healthcare Berhad (KPJ) is a healthcare service provider that offers medical services. The center offers services in the areas of anaesthesiology, cardiology and cardiothoracic surgery, child psychiatry, clinic pathology, occupational health services, orthopaedic and trauma surgery, diet …
  • NTPC Ltd (NTPC):企業の財務・戦略的SWOT分析
    NTPC Ltd (NTPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Chong Kun Dang Pharmaceutical Corp (185750):企業の財務・戦略的SWOT分析
    Chong Kun Dang Pharmaceutical Corp (185750) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Great Basin Scientific Inc (GBSN)-医療機器分野:企業M&A・提携分析
    Summary Great Basin Scientific Inc (Great Basin) is a molecular diagnostics company that offers technology products. The company develops and distributes point-of-care technology and products to improve automation, throughput, scalability, reliability and ease-of-use in rapid diagnostic testing. It …
  • American Equity Investment Life Holding Company:企業の戦略・SWOT・財務情報
    American Equity Investment Life Holding Company - Strategy, SWOT and Corporate Finance Report Summary American Equity Investment Life Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Centre for Drug Research and Development:製薬・医療:M&Aディール及び事業提携情報
    Summary Centre for Drug Research and Development (CDRD) is a drug development and commercialization center that provides scientific infrastructure to transform discoveries into innovative therapeutic products and improved health outcomes. The center's drug development platform includes target valida …
  • Ascena Retail Group Inc:企業の戦略的SWOT分析
    Ascena Retail Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Banco Comercial Portugues S.A:企業のM&A・事業提携・投資動向
    Banco Comercial Portugues S.A - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco Comercial Portugues S.A Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • University of Pennsylvania-医療機器分野:企業M&A・提携分析
    Summary University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, cri …
  • Verizon Communications Inc.:企業のM&A・事業提携・投資動向
    Verizon Communications Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Verizon Communications Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Viralytics Ltd (VLA)-製薬・医療分野:企業M&A・提携分析
    Summary Viralytics Ltd (Viralytics), formerly Psiron Ltd is a provider of development and commercialisation of oncolytic immunotherapies. The company develops oncolytic immunotherapies for the treatment of different types of cancers. It offers cavataktm, a proprietary formulation for the common cold …
  • Naftna industrija Srbije ad (NIIS):電力:M&Aディール及び事業提携情報
    Summary Naftna industrija Srbije ad (NIS), a subsidiary of Gazprom Neft, is an integrated energy company that conducts oil and gas exploration, production and refining, and sales and distribution of a broad range of petroleum products. Its refined products include motor fuel, diesel fuel, heating oi …
  • Alliance Oil Co Ltd:企業の戦略的SWOT分析
    Alliance Oil Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Dr. Ci:Labo Co., Ltd.:企業の戦略・SWOT・財務情報
    Dr. Ci:Labo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dr. Ci:Labo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • MMX Mineracao e Metalicos SA:企業の戦略・SWOT・財務分析
    MMX Mineracao e Metalicos SA - Strategy, SWOT and Corporate Finance Report Summary MMX Mineracao e Metalicos SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Specialised Therapeutics Australia Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Specialised Therapeutics Australia Pty Ltd (STA) is a biopharmaceutical company that develops and commercializes therapies and technologies for unmet medical needs. The company’s product portfolio includes abraxane, gliolan, oncotype dx, iclusig, oncotype dx prostate and aloxi. Its pipeline …
  • Tiziana Life Sciences Plc (TILS):企業の財務・戦略的SWOT分析
    Tiziana Life Sciences Plc (TILS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Energia Argentina SA:電力:M&Aディール及び事業提携情報
    Summary Energia Argentina SA (ENARSA) is a state owned energy company that explores and exploits hydrocarbons in solid, liquid and gaseous states. It stores, transports, distributes, markets and industrializes the hydrocarbons and their derivatives. Energia conducts design, construction, commissioni …
  • Pfizer Inc (PFE):医療機器:M&Aディール及び事業提携情報
    Summary Pfizer Inc (Pfizer) is a biopharmaceutical company, which discovers, develops, manufactures and markets healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products to treat various conditions including infection, cancer, inflammation, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆